Biosynthesis of promatrix metalloproteinase-9/chondroitin sulphate proteoglycan heteromer involves a rottlerin-sensitive pathway

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Malla, Nabin ^a   Berg, Eli ^a   Moens, Ugo ^a   Uhlin Hansen, Lars ^a   Winberg, Jan Olof ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; GELATINASE B; MESSENGER RNA; PROTEIN KINASE C; PROTEOGLYCAN; ACETOPHENONE DERIVATIVE; BENZOPYRAN DERIVATIVE; DRUG DERIVATIVE; ISOENZYME; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOLOL MYRISTATE ACETATE; PROTEOCHONDROITIN SULFATE; ROTTLERIN;

ARTICLE; CELL COUNT; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; MACROPHAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BIOSYNTHESIS; CELL LINE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE; SIGNAL TRANSDUCTION; TIME;

ACETOPHENONES; BENZOPYRANS; CELL LINE; CELL SURVIVAL; CHONDROITIN SULFATE PROTEOGLYCANS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOENZYMES; MACROPHAGES; MATRIX METALLOPROTEINASE 9; PROTEIN KINASE C; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; RNA, MESSENGER; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS;

EID: 79957793227     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020616     Document Type: Article

References (101)

1. Hascall VC, Calabro A, Midura RJ, Yanagishita M, (1994) Isolation and characterization of proteoglycans. Methods Enzymol 230: 390-417.
2. Kjellen L, Lindahl U, (1991) Proteoglycans: structures and interactions [published erratum appears in Annu Rev Biochem 1992;61:following viii]. Annu Rev Biochem 60: 443-475.
3. Edwards IJ, Xu H, Obunike JC, Goldberg IJ, Wagner WD, (1995) Differentiated macrophages synthesize a heparan sulphate proteoglycan and an oversulphated chondroitin sulphate proteoglycan that bind lipoprotein lipase. Arterioscler Thromb Vasc Biol 15: 400-409.
4. Kolset SO, Gallagher JT, (1990) Proteoglycans in haemopoietic cells. Biochim Biophys Acta 1032: 191-211.
5. Kolset SO, Prydz K, Pejler G, (2004) Intracellular proteoglycans. Biochem J 379: 217-227.
6. Kolset SO, Salmivirta M, (1999) Cell surface heparan sulphate proteoglycans and lipoprotein metabolism. Cell Mol Life Sci 56: 857-870.
7. Uhlin-Hansen L, Wik T, Kjellen L, Berg E, Forsdahl F, et al. (1993) Proteoglycan metabolism in normal and inflammatory human macrophages. Blood 82: 2880-2889.
8. Makatsori E, Lamari FN, Theocharis AD, Anagnostides S, Hjerpe A, et al. (2003) Large matrix proteoglycans, versican and perlecan, are expressed and secreted by human leukemic monocytes. Anticancer Res 23: 3303-3309.
9. Øynebråten I, Hansen B, Smedsrød B, Uhlin-Hansen L, (2000) Serglycin secreted by leucocytes is efficiently eliminated from the circulation by sinusoidal scavanger endothelial cells in the liver. J Leukoc Biol 67: 183-188.
10. Kolset SO, Mann DM, Uhlin-Hansen L, Winberg JO, Ruoslahti E, (1996) Serglycin-binding proteins in activated macrophages and platelets. J Leukoc Biol 59: 545-554.
11. Metkar SS, Wang B, Aguilar-Santelises M, Raja SM, Uhlin-Hansen L, et al. (2002) Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. Immunity 16: 417-428.
12. Theocharis AD, Seidel C, Borset M, Dobra K, Baykov V, et al. (2006) Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro. J Biol Chem 281: 35116-35128.
13. Butler GS, Overall CM, (2009) Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics. Biochemistry 48: 10830-10845.
14. Flannery CR, (2006) MMPs and ADAMTSs: functional studies. Front Biosci 11: 544-569.
15. Nagase H, Visse R, Murphy G, (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69: 562-573.
16. Ra HJ, Parks WC, (2007) Control of matrix metalloproteinase catalytic activity. Matrix Biol 26: 587-596.
17. Strongin AY, (2006) Mislocalization and unconventional functions of cellular MMPs in cancer. Cancer Metastasis Rev 25: 87-98.
18. Cawston TE, Wilson AJ, (2006) Understanding the role of tissue degrading enzymes and their inhibitors in development and disease. Best Pract Res Clin Rheumatol 20: 983-1002.
19. Malemud CJ, (2006) Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 11: 1696-1701.
20. Hadler-Olsen E, Fadnes B, Sylte I, Uhlin-Hansen L, Winberg JO, (2011) Regulation of matrix metalloproteinase activity in health and disease. FEBS J 278: 28-45.
21. Woessner JF Jr, (1995) Quantification of matrix metalloproteinases in tissue samples. Methods Enzymol 248: 510-528.
22. Allan JA, Docherty AJ, Barker PJ, Huskisson NS, Reynolds JJ, et al. (1995) Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem J 309: 299-306.
23. Collier IE, Krasnov PA, Strongin AY, Birkedal-Hansen H, Goldberg GI, (1992) Alanine scanning mutagenesis and functional analysis of the fibronectin-like collagen-binding domain from human 92-kDa type IV collagenase. J Biol Chem 267: 6776-6781.
24. Hornebeck W, Bellon G, Emonard H, (2005) Fibronectin type II (FnII)-like modules regulate gelatinase A activity. Pathol Biol (Paris) 53: 405-410.
25. Murphy G, Nguyen Q, Cockett MI, Atkinson SJ, Allan JA, et al. (1994) Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. J Biol Chem 269: 6632-6636.
26. O'Farrell TJ, Pourmotabbed T, (1998) The fibronectin-like domain is required for the type V and XI collagenolytic activity of gelatinase B. Arch Biochem Biophys 354: 24-30.
27. Shipley JM, Doyle GA, Fliszar CJ, Ye QZ, Johnson LL, et al. (1996) The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats. J Biol Chem 271: 4335-4341.
28. Steffensen B, Wallon UM, Overall CM, (1995) Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen. J Biol Chem 270: 11555-11566.
29. Strongin AY, Collier IE, Krasnov PA, Genrich LT, Marmer BL, et al. (1993) Human 92 kDa type IV collagenase: functional analysis of fibronectin and carboxyl-end domains. Kidney Int 43: 158-162.
30. Xu X, Chen Z, Wang Y, Yamada Y, Steffensen B, (2005) Functional basis for the overlap in ligand interactions and substrate specificities of matrix metalloproteinases-9 and-2. Biochem J 392: 127-134.
31. Xu X, Wang Y, Lauer-Fields JL, Fields GB, Steffensen B, (2004) Contributions of the MMP-2 collagen binding domain to gelatin cleavage. Substrate binding via the collagen binding domain is required for hydrolysis of gelatin but not short peptides. Matrix Biol 23: 171-181.
32. Goldberg GI, Strongin A, Collier IE, Genrich LT, Marmer BL, (1992) Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 267: 4583-4591.
33. Hibbs MS, Hasty KA, Seyer JM, Kang AH, Mainardi CL, (1985) Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem 260: 2493-2500.
34. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N, (1993) Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268: 10425-10432.
35. Malla N, Sjoli S, Winberg JO, Hadler-Olsen E, Uhlin-Hansen L, (2008) Biological and pathobiological functions of gelatinase dimers and complexes. Connect Tissue Res 49: 180-184.
36. Olson MW, Bernardo MM, Pietila M, Gervasi DC, Toth M, et al. (2000) Characterization of the Monomeric and Dimeric Forms of Latent and Active Matrix Metalloproteinase-9. Differential rates for activation by stromelysin 1. J Biol Chem 275: 2661-2668.
37. Triebel S, Blaser J, Reinke H, Tschesche H, (1992) A 25 kDa alpha 2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase. FEBS Lett 314: 386-388.
38. Winberg JO, Kolset SO, Berg E, Uhlin-Hansen L, (2000) Macrophages secrete matrix metalloproteinase 9 covalently linked to the core protein of chondroitin sulphate proteoglycans. J Mol Biol 304: 669-680.
39. Malla N, Berg E, Uhlin-Hansen L, Winberg JO, (2008) Interaction of pro-matrix metalloproteinase-9/proteoglycan heteromer with gelatin and collagen. J Biol Chem 283: 13652-13665.
40. Winberg JO, Berg E, Kolset SO, Uhlin-Hansen L, (2003) Calcium-induced activation and truncation of promatrix metalloproteinase-9 linked to the core protein of chondroitin sulphate proteoglycans. Eur J Biochem 270: 3996-4007.
41. Loennechen T, Mathisen B, Hansen J, Lindstad RI, El-Gewely SA, et al. (2003) Colchicine induces membrane-associated activation of matrix metalloproteinase-2 in osteosarcoma cells in an S100A4-independent manner. Biochem Pharmacol 66: 2341-2353.
42. Mathisen B, Lindstad RI, Hansen J, El-Gewely SA, Maelandsmo GM, et al. (2003) S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells. Clin Exp Metastasis 20: 701-711.
43. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, et al. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem J 408: 297-315.
44. Kontny E, Kurowska M, Szczepanska K, Maslinski W, (2000) Rottlerin, a PKC isozyme-selective inhibitor, affects signaling events and cytokine production in human monocytes. J Leukoc Biol 67: 249-258.
45. Kim SJ, Kim KH, (1997) Insulin rapidly stimulates ERK2 in the membrane of osteoblast-like UMR-106 cell. Biochem Mol Biol Int 43: 1023-1031.
46. Van Ranst M, Norga K, Masure S, Proost P, Vandekerckhove F, et al. (1991) The cytokine-protease connection: identification of a 96-kD THP-1 gelatinase and regulation by interleukin-1 and cytokine inducers. Cytokine 3: 231-239.
47. Huang Z, Wang L, Meng S, Wang Y, Chen T, et al. (2009) Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages. Int J Cardiol (DOI;10.1016/j.ijcard.2009.06.023).
48. Xie B, Laouar A, Huberman E, (1998) Fibronectin-mediated cell adhesion is required for induction of 92-kDa type IV collagenase/gelatinase (MMP-9) gene expression during macrophage differentiation. The signaling role of protein kinase C-beta. J Biol Chem 273: 11576-11582.
49. Zhou J, Zhu P, Jiang JL, Zhang Q, Wu ZB, et al. (2005) Involvement of CD147 in overexpression of MMP-2 and MMP-9 and enhancement of invasive potential of PMA-differentiated THP-1. BMC Cell Biol 6: 25.
50. Schwende H, Fitzke E, Ambs P, Dieter P, (1996) Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J Leukoc Biol 59: 555-561.
51. Ron D, Kazanietz MG, (1999) New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J 13: 1658-1676.
52. Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, et al. (1994) Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199: 93-98.
53. Springael C, Thomas S, Rahmouni S, Vandamme A, Goldman M, et al. (2007) Rottlerin inhibits human T cell responses. Biochem Pharmacol 73: 515-525.
54. Hallen A, (1972) Chromatography of acidic glycosaminoglycans on DEAE-cellulose. J Chromatogr 71: 83-91.
55. Kolset SO, Ehlorsson J, Kjellen L, Lindahl U, (1986) Effect of benzyl beta-D-xyloside on the biosynthesis of chondroitin sulphate proteoglycan in cultured human monocytes. Biochem J 238: 209-216.
56. Hendriks BS, Seidl KM, Chabot JR, (2010) Two additive mechanisms impair the differentiation of 'substrate-selective' p38 inhibitors from classical p38 inhibitors in vitro. BMC Syst Biol 4: 23.
57. Chevalier D, Allen BG, (2000) Two distinct forms of MAPKAP kinase-2 in adult cardiac ventricular myocytes. Biochemistry 39: 6145-6156.
58. Zu YL, Ai Y, Gilchrist A, Labadia ME, Sha'afi RI, et al. (1996) Activation of MAP kinase-activated protein kinase 2 in human neutrophils after phorbol ester or fMLP peptide stimulation. Blood 87: 5287-5296.
59. Davies SP, Reddy H, Caivano M, Cohen P, (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105.
60. Murphy G, Nagase H, (2008) Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair? Nat Clin Pract Rheumatol 4: 128-135.
61. Overall CM, (2002) Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites. Mol Biotechnol 22: 51-86.
62. Overall CM, McQuibban GA, Clark-Lewis I, (2002) Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics. Biol Chem 383: 1059-1066.
63. Duffy MJ, McGowan PM, Gallagher WM, (2008) Cancer invasion and metastasis: changing views. J Pathol 214: 283-293.
64. Martin MD, Matrisian LM, (2007) The other side of MMPs: protective roles in tumor progression. Cancer Metastasis Rev 26: 717-724.
65. Rundhaug JE, (2005) Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9: 267-285.
66. Liu WS, Heckman CA, (1998) The sevenfold way of PKC regulation. Cell Signal 10: 529-542.
67. Soltoff SP, (2007) Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta. Trends Pharmacol Sci 28: 453-458.
68. Parmer TG, Ward MD, Hait WN, (1997) Effects of rottlerin, an inhibitor of calmodulin-dependent protein kinase III, on cellular proliferation, viability, and cell cycle distribution in malignant glioma cells. Cell Growth Differ 8: 327-334.
69. Takizawa T, Kato M, Suzuki M, Tachibana A, Motegi Y, et al. (2003) Distinct isoforms of protein kinase C are involved in human eosinophil functions induced by platelet-activating factor. Int Arch Allergy Immunol 131 (Suppl 1): 15-19.
70. Sarkar K, Kruhlak MJ, Erlandsen SL, Shaw S, (2005) Selective inhibition by rottlerin of macropinocytosis in monocyte-derived dendritic cells. Immunology 116: 513-524.
71. Mosior M, Newton AC, (1995) Mechanism of interaction of protein kinase C with phorbol esters. Reversibility and nature of membrane association. J Biol Chem 270: 25526-25533.
72. Shirai Y, Saito N, (2002) Activation mechanisms of protein kinase C: maturation, catalytic activation, and targeting. J Biochem 132: 663-668.
73. Shirai Y, Sakai N, Saito N, (1998) Subspecies-specific targeting mechanism of protein kinase C. Jpn J Pharmacol 78: 411-417.
74. Conquer JA, Kandel RA, Cruz TF, (1992) Interleukin 1 and phorbol 12-myristate 13-acetate induce collagenase and PGE2 production through a PKC-independent mechanism in chondrocytes. Biochim Biophys Acta 1134: 1-6.
75. Ikeda C, Morita I, Mori A, Fujimoto K, Suzuki T, et al. (1994) Phorbol ester stimulates acetylcholine synthesis in cultured endothelial cells isolated from porcine cerebral microvessels. Brain Res 655: 147-152.
76. Kang HS, Park EK, Kim KH, Park JY, Choi JY, et al. (2004) Receptor activator of nuclear factor-kappaB is induced by a rottlerin-sensitive and p38 MAP kinase-dependent pathway during monocyte differentiation. Mol Cells 17: 438-445.
77. Malakooti J, Sandoval R, Amin MR, Clark J, Dudeja PK, et al. (2006) Transcriptional stimulation of the human NHE3 promoter activity by PMA: PKC independence and involvement of the transcription factor EGR-1. Biochem J 396: 327-336.
78. Brose N, Rosenmund C, (2002) Move over protein kinase C, you've got company: alternative cellular effectors of diacylglycerol and phorbol esters. J Cell Sci 115: 4399-4411.
79. Mietus-Snyder M, Glass CK, Pitas RE, (1998) Transcriptional activation of scavenger receptor expression in human smooth muscle cells requires AP-1/c-Jun and C/EBPbeta: both AP-1 binding and JNK activation are induced by phorbol esters and oxidative stress. Arterioscler Thromb Vasc Biol 18: 1440-1449.
80. O'Sullivan AW, Wang JH, Redmond HP, (2009) The role of P38 MAPK and PKC in BLP induced TNF-alpha release, apoptosis, and NFkappaB activation in THP-1 monocyte cells. J Surg Res 151: 138-144.
81. Traore K, Trush MA, George M Jr, Spannhake EW, Anderson W, et al. (2005) Signal transduction of phorbol 12-myristate 13-acetate (PMA)-induced growth inhibition of human monocytic leukemia THP-1 cells is reactive oxygen dependent. Leuk Res 29: 863-879.
82. Dieter P, Schwende H, (2000) Protein kinase C-alpha and-beta play antagonistic roles in the differentiation process of THP-1 cells. Cell Signal 12: 297-302.
83. Siljander P, Hurme M, (1993) Continuous presence of phorbol ester is required for its IL-1 beta mRNA stabilizing effect. FEBS Lett 315: 81-84.
84. Cuschieri J, Umanskiy K, Solomkin J, (2004) PKC-zeta is essential for endotoxin-induced macrophage activation. J Surg Res 121: 76-83.
85. Datta R, Imamura K, Goldman SJ, Dianoux AC, Kufe DW, et al. (1992) Functional expression of the macrophage colony-stimulating factor receptor in human THP-1 monocytic leukemia cells. Blood 79: 904-912.
86. Hashimoto S, Morohoshi K, Suzuki T, Matsushima K, (2003) Lipopolysaccharide-inducible gene expression profile in human monocytes. Scand J Infect Dis 35: 619-627.
87. Herrera-Velit P, Knutson KL, Reiner NE, (1997) Phosphatidylinositol 3-kinase-dependent activation of protein kinase C-zeta in bacterial lipopolysaccharide-treated human monocytes. J Biol Chem 272: 16445-16452.
88. Trautwein C, Rakemann T, Brenner DA, Streetz K, Licato L, et al. (1998) Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice. Gastroenterology 114: 1035-1045.
89. Turner NA, Das A, Warburton P, O'Regan DJ, Ball SG, et al. (2009) Interleukin-1alpha stimulates proinflammatory cytokine expression in human cardiac myofibroblasts. Am J Physiol Heart Circ Physiol 297: H1117-1127.
90. Cawston TE, Milner JM, Catterall JB, Rowan AD, (2003) Cytokine synergy, collagenases and cartilage collagen breakdown. Biochem Soc Symp pp. 125-133.
91. Litherland GJ, Dixon C, Lakey RL, Robson T, Jones D, et al. (2008) Synergistic collagenase expression and cartilage collagenolysis are phosphatidylinositol 3-kinase/Akt signaling-dependent. J Biol Chem 283: 14221-14229.
92. Mendes Sdos S, Candi A, Vansteenbrugge M, Pignon MR, Bult H, et al. (2009) Microarray analyses of the effects of NF-kappaB or PI3K pathway inhibitors on the LPS-induced gene expression profile in RAW264.7 cells: synergistic effects of rapamycin on LPS-induced MMP9-overexpression. Cell Signal 21: 1109-1122.
93. Uttamsingh S, Bao X, Nguyen KT, Bhanot M, Gong J, et al. (2008) Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene 27: 2626-2634.
94. Bannikov GA, Mattoon JS, Abrahamsen EJ, Premanandan C, Green-Church KB, et al. (2007) Biochemical and enzymatic characterization of purified covalent complexes of matrix metalloproteinase-9 and haptoglobin released by bovine granulocytes in vitro. Am J Vet Res 68: 995-1004.
95. Bjorklund M, Koivunen E, (2005) Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 1755: 37-69.
96. Fernandez CA, Yan L, Louis G, Yang J, Kutok JL, et al. (2005) The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res 11: 5390-5395.
97. Fjeldstad K, Kolset SO, (2005) Decreasing the metastatic potential in cancers--targeting the heparan sulphate proteoglycans. Curr Drug Targets 6: 665-682.
98. Murphy G, Nagase H, (2008) Progress in matrix metalloproteinase research. Mol Aspects Med 29: 290-308.
99. Parks WC, Wilson CL, Lopez-Boado YS, (2004) Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4: 617-629.
100. Provatopoulou X, Gounaris A, Kalogera E, Zagouri F, Flessas I, et al. (2009) Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease. BMC Cancer 9: 390.
101. Yan L, Borregaard N, Kjeldsen L, Moses MA, (2001) The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 276: 37258-37265.